Mark Pollack to Exotoxins
This is a "connection" page, showing publications Mark Pollack has written about Exotoxins.
Connection Strength
0.400
-
Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
Score: 0.058
-
Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11.
Score: 0.056
-
Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J Infect Dis. 1982 May; 145(5):688-98.
Score: 0.054
-
Pseudomonas aeruginosa exotoxin A. N Engl J Med. 1980 Jun 12; 302(24):1360-2.
Score: 0.048
-
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86.
Score: 0.043
-
Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect Immun. 1978 Mar; 19(3):1092-6.
Score: 0.041
-
Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2. Infect Immun. 1978 Jan; 19(1):29-33.
Score: 0.040
-
Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography. Infect Immun. 1978 Jan; 19(1):66-70.
Score: 0.040
-
Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect Immun. 1986 Jun; 52(3):756-62.
Score: 0.018
-
Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect Immun. 1977 Dec; 18(3):596-602.
Score: 0.002